Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 8Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lung Neoplasms 4Glioblastoma 4Uterine Cervical Neoplasms 3Neoplasm Metastasis 3Head and Neck Neoplasms 3Brain Neoplasms 3Rectal Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Lymphoma, B-Cell 2Gliosarcoma 2Esophageal Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Skin Neoplasms 1Sarcoma 1Recurrence 1Pharyngeal Neoplasms 1Pain 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Neuroblastoma 1Neoplasms 1Mouth Neoplasms 1Meningeal Carcinomatosis 1Melanoma 1

Interventions

Temozolomide 6Methotrexate 5Radiotherapy 4Carboplatin 4Magnetic Resonance Spectroscopy 3Vincristine 2Thiotepa 2Specimen Handling 2Procarbazine 2Nivolumab 2Filgrastim 2Carmustine 2Bevacizumab 2sodium thiosulfate 1selinexor 1sargramostim 1motexafin gadolinium 1irinotecan sucrosofate 1infigratinib 1fluoroacetic acid 1Trastuzumab 1Topotecan 1Standard of Care 1Rituximab 1Radiation 1RG7388 1Psychiatric Rehabilitation 1Practice Guidelines as Topic 1Peripheral Blood Stem Cell Transplantation 1Oxaloacetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Central Nervous System Neoplasms × Radiation × Clear all
NCT03554707 2026-05-08

SGT-53 in Children With Recurrent or Progressive CNS Malignancies

SynerGene Therapeutics, Inc.

Phase EARLY_PHASE1 Withdrawn
CNS

Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡